| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8442559 | European Journal of Cancer | 2015 | 9 Pages |
Abstract
In this study, clinical tumour size emerged as the only predictor for DRFI after pCR, with T3 and T4 tumours having an increased risk for distant recurrence compared to T1-2 tumours.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
F. Fei, C. Messina, L. Slaets, C. Chakiba, D. Cameron, J. Bogaerts, H. Bonnefoi,